Anti-Mouse CD51 (Integrin alpha V) PE

Also known as: Integrin aV, ITGAV, Vitronectin receptor

Clone: RMV-7

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# 12-0512

Cat. No. Size
12-0512-81 50 ug
12-0512-82 100 ug
12-0512-83 200 ug
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Anti-Mouse CD51 (Integrin alpha V) PE.

Staining of BALB/c splenocytes with staining buffer (autofluorescence) (open histogram) or 0.25 ug...View More

  • Data for Anti-Mouse CD51 (Integrin alpha V) PE.
Description

Description: The RMV-7 monoclonal antibody reacts with the mouse CD51 molecule, the integrin alpha v chain. This approximately 120 kDa surface molecule non-covalently associates with the β subunits of the integrin family including β3 (CD61), β1 (CD29), β5 and β6 to form receptors for extracellular matrix components. Heterodimers of CD51/CD61 are expressed by platelets, T cells and granulocytes and mediate adhesion to fibrinogen, fibronectin, vitronectin and thrombospondin.

Details
Host Rat
Isotype IgG1, kappa
Reactivity Mouse
Conjugate PE
Laser Blue Laser, Green Laser, Yellow-Green Laser
Emit 575 nm
Excite 488 - 561 nm
Reported Applications Flow Cytometric Analysis
Documentation
TDS Link Download TDS
Additional Formats
Cat. No. Name Excite Emit Application Reg.
13-0512 Anti-Mouse CD51 (Integrin alpha V) Biotin FC RUO
14-0512 Anti-Mouse CD51 (Integrin alpha V) Purified FC, FA, IP, WB RUO
Related Products
Cat. No. Name Excite Emit Application Reg.
12-4301 Rat IgG1 K Isotype Control PE 488 - 561 nm FC RUO
References

References:
Tsujimura, K., T. Takahashi, et al. (1998). "Two types of anti-TL (thymus leukemia) CTL clones with distinct target specificities: differences in cytotoxic mechanisms and accessory molecule requirements." J Immunol 160(11): 5253-61.
Takahashi, K., T. Nakamura, et al. (1991). "Antigen-independent T cell activation mediated by a very late activation antigen-like extracellular matrix receptor." Eur J Immunol 21(6): 1559-62.
Takahashi, K., T. Nakamura, M. Koyanagi, K. Kato, Y. Hashimoto, H. Yagita, and K. Okumura. 1990. A murine very late activation antigen-like extracellular matrix receptor involved in CD2- and lymphocyte function-associated antigen-1-independent killer-target cell interaction. J. Immunol. 145:4371-4379